Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results
Biora initiating preclinical testing with pharma collaborator’s molecule following recent data exceeding the company’s target…
Biora initiating preclinical testing with pharma collaborator’s molecule following recent data exceeding the company’s target…
Positive topline results from single and multiple ascending dose parts of the Phase 1 study…
A clinical trial generating safety, pharmacokinetics, and dosing data with the goal of providing information…
Clinical updates on track for NKX101 in first half of 2023 and NKX019 in full…
Q4 2022 DANYELZA® record net product revenues of $16.4 million, driving YoY growth of 71%…
`Four patients enrolled in open-label Phase 1b kidney transplant trial with clinical data on first…
50 & Forever by Rotation will immerse fans in hip-hop’s indelible history, celebrating both the…
ROCKVILLE, Md., March 30, 2023 (GLOBE NEWSWIRE) — In a release published March 29, 2023…
BOSTON–(BUSINESS WIRE)–Mytide, the tech-enabled biotechnology manufacturing services company, today announced the appointment of Dr. Martina…
Offer applies for newly deployed endpoints through April 2023 ELLICOTT CITY, Md., March 30, 2023…
Melville, New York–(Newsfile Corp. – March 30, 2023) – Gallagher University announces the launch of…
Road Town, British Virgin Islands–(Newsfile Corp. – March 30, 2023) – LBank Exchange, a global…
Lake Forest, California–(Newsfile Corp. – March 30, 2023) – Omar’s Exotic Birds, a leading breeder…
WILMINGTON, Del.–(BUSINESS WIRE)–A new survey from WSFS Bank, the primary subsidiary of WSFS Financial Corporation…
Longtime users of the workflow automation platform are tackling industry-specific challenges with service providers’ help,…
Clinical data published in Human Vaccines & Immunotherapeutics shows for the first time the equivalent…
National Pest Management Association shares advice on protecting health and homes against pests that thrive…
Funds will advance the cloud-based prevention, detection, and analytics of file-borne threats and to accelerate…
The proposed combination of Novozymes and Chr. Hansen has now been approved by each company’s…
HONG KONG, Mar 30, 2023 – (ACN Newswire) – Ocumension Therapeutics (“Ocumension” or the “Company”,…